Location History:
- Portland, OR (US) (2010)
- San Francisco, CA (US) (2003 - 2013)
Company Filing History:
Years Active: 2003-2013
Title: Michael G Roepel: Innovator in Cysteine Protease Inhibitors
Introduction
Michael G Roepel is a prominent inventor based in San Francisco, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit cysteine proteases. With a total of 7 patents to his name, Roepel's work has the potential to impact the treatment of various diseases.
Latest Patents
One of Roepel's latest patents focuses on alpha ketoamide compounds as cysteine protease inhibitors. This invention is directed towards compounds that inhibit cysteine proteases, specifically cathepsins B, K, L, F, and S. These compounds are particularly useful in treating diseases mediated by these proteases. The patent also includes pharmaceutical compositions comprising these compounds and processes for preparing them.
Career Highlights
Throughout his career, Roepel has worked with notable companies such as Virobay, Inc. and Syntex (U.S.A.) Inc. His experience in these organizations has contributed to his expertise in the field of drug development and innovation.
Collaborations
Roepel has collaborated with several professionals in his field, including Michael Graupe and John O Link. These collaborations have likely enriched his research and development efforts.
Conclusion
Michael G Roepel is a distinguished inventor whose work in cysteine protease inhibitors showcases his commitment to advancing pharmaceutical science. His contributions are poised to make a significant impact on the treatment of diseases related to cysteine proteases.